Annual Report 2024

Shareholdings

Shareholdings of members of the Executive Committee

As of the end of financial year 2024, the members of the Executive Committee held the following shares and performance share units in the company:

Shareholdings at December 31, 2024

 

medmix shares

 

Unvested performance share units (PSU) 2)

 

Restricted share units (RSU)

 

Total

René Willi

 

10’065

 

36’595

 

123’206

 

169’866

Jennifer Dean

 

6’841

 

28’724

 

0

 

35’565

Itee Satpathy

 

0

 

19’050

 

0

 

19’050

Xavier Schops

 

2’600

 

14’657

 

0

 

17’257

Girts Cimermans 1)

 

7’000

 

65’823

 

0

 

72’823

1) medmix Shares as per December 2024

2) Total of unvested PSU grants: 2022, 2023, 2024

As of the end of financial year 2023, the members of the Executive Committee held the following shares and performance share units in the company:

Shareholdings at December 31, 2023

 

medmix shares

 

Performance share units (PSU) 2023

 

Performance share units (PSU) 2022 1)

Girts Cimermans

 

7’000

 

30’813

 

35’010

Jennifer Dean

 

1’976

 

8’964

 

10’001

Itee Satpathy

 

0

 

7’283

 

3’838

Xavier Schops 2)

 

950

 

5’603

 

1’125

1) 2022 PSU included compensation adjustment for Sulzer PSP

2) Listing 2022 and 2023 PSP grants including before EC membership

Shareholdings of the Board of Directors

As of the end of 2024, the members of the Board of Directors held the following shares and restricted share units in the company:

Shareholdings at December 31, 2024

 

medmix shares

 

Restricted share units (RSU)

 

Total share awards and shares

Rob ten Hoedt, Chairman

 

3’746

 

14’934

 

18’680

Barbara Angehrn

 

2’286

 

6’813

 

9’099

Daniel O. Flammer

 

2’286

 

6’813

 

9’099

David Metzger

 

5’187

 

6’763

 

11’950

Marco Musetti

 

15’210

 

7’599

 

22’809

Susanne Hundsbaek-Pedersen 1)

 

 

 

4’143

 

4’143

1) Member of the Board of Directors since April 24, 2024.

As of the end of 2023, the members of the Board of Directors held the following shares and restricted share units in the company:

Shareholdings at December 31, 2023

 

medmix shares

 

Restricted share units (RSU)

 

Total share awards and shares

Rob ten Hoedt, Chairman

 

690

 

8’430

 

9’120

Barbara Angehrn

 

619

 

4’337

 

4’956

Daniel O. Flammer

 

619

 

4’337

 

4’956

David Metzger

 

1’571

 

4’236

 

5’807

Greg Poux-Guillaume

 

45’596

 

6’439

 

52’035

Marco Musetti

 

13’039

 

5’149

 

18’188

René Willi

 

619

 

4’337

 

4’956